These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 30460447)

  • 21. Morphometric changes of sensorimotor structures in focal dystonia.
    Obermann M; Yaldizli O; De Greiff A; Lachenmayer ML; Buhl AR; Tumczak F; Gizewski ER; Diener HC; Maschke M
    Mov Disord; 2007 Jun; 22(8):1117-23. PubMed ID: 17443700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pallidal and thalamic deep brain stimulation in myoclonus-dystonia.
    Gruber D; Kühn AA; Schoenecker T; Kivi A; Trottenberg T; Hoffmann KT; Gharabaghi A; Kopp UA; Schneider GH; Klein C; Asmus F; Kupsch A
    Mov Disord; 2010 Aug; 25(11):1733-43. PubMed ID: 20623686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subjective assessment of effectiveness, quality of life, and psychological status of patients receiving botulinum toxin therapy for hemifacial spasm, blepharospasm, or cervical dystonia.
    Kako T; Nokura K; Kaneko H; Izawa H
    Fujita Med J; 2021; 7(1):12-17. PubMed ID: 35111538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Botulinum toxin for treatment of the focal dystonia].
    Nakamura Y
    Rinsho Shinkeigaku; 2017 Jul; 57(7):367-372. PubMed ID: 28652522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deep brain stimulation in children and young adults with secondary dystonia: the Children's Hospital Los Angeles experience.
    Olaya JE; Christian E; Ferman D; Luc Q; Krieger MD; Sanger TD; Liker MA
    Neurosurg Focus; 2013 Nov; 35(5):E7. PubMed ID: 24175867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Botulinum toxin type B in the management of dystonia non-responsive to botulinum toxin type A].
    Cardoso F
    Arq Neuropsiquiatr; 2003 Sep; 61(3A):607-10. PubMed ID: 14513166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality of life in focal, segmental, and generalized dystonia.
    Page D; Butler A; Jahanshahi M
    Mov Disord; 2007 Feb; 22(3):341-7. PubMed ID: 17216640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiological, clinical and genetic aspects of adult onset isolated focal dystonia in Ireland.
    Williams L; McGovern E; Kimmich O; Molloy A; Beiser I; Butler JS; Molloy F; Logan P; Healy DG; Lynch T; Walsh R; Cassidy L; Moriarty P; Moore H; McSwiney T; Walsh C; O'Riordan S; Hutchinson M
    Eur J Neurol; 2017 Jan; 24(1):73-81. PubMed ID: 27647704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-motor symptoms in patients with adult-onset focal dystonia: Sensory and psychiatric disturbances.
    Conte A; Berardelli I; Ferrazzano G; Pasquini M; Berardelli A; Fabbrini G
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S111-4. PubMed ID: 26360238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is deep brain stimulation (DBS) a safe and effective treatment for adults with dystonia? - A Cochrane Review summary with commentary.
    Cecchi F
    NeuroRehabilitation; 2019 Dec; 45(4):567-569. PubMed ID: 31868700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botulinum neurotoxin type A free of complexing proteins (XEOMIN) in focal dystonia.
    Jost WH; Blümel J; Grafe S
    Drugs; 2007; 67(5):669-83. PubMed ID: 17385940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dystonia: A review.
    Batla A
    Neurol India; 2018; 66(Supplement):S48-S58. PubMed ID: 29503327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of dystonia.
    Jankovic J
    Lancet Neurol; 2006 Oct; 5(10):864-72. PubMed ID: 16987733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical phenomenology of dystonia.
    Colosimo C; Berardelli A
    Int Rev Neurobiol; 2011; 98():509-24. PubMed ID: 21907098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What parents think and feel about deep brain stimulation in paediatric secondary dystonia including cerebral palsy: A qualitative study of parental decision-making.
    Austin A; Lin JP; Selway R; Ashkan K; Owen T
    Eur J Paediatr Neurol; 2017 Jan; 21(1):185-192. PubMed ID: 27658770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of primary late-onset focal dystonia in the Belgrade population.
    Pekmezović T; Ivanović N; Svetel M; Nalić D; Smiljković T; Raicević R; Kostić VS
    Mov Disord; 2003 Nov; 18(11):1389-92. PubMed ID: 14639690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prevalence of depression in adult onset idiopathic dystonia: Systematic review and metaanalysis.
    Medina Escobar A; Pringsheim T; Goodarzi Z; Martino D
    Neurosci Biobehav Rev; 2021 Jun; 125():221-230. PubMed ID: 33662441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cervical dystonia pathophysiology and treatment options.
    Velickovic M; Benabou R; Brin MF
    Drugs; 2001; 61(13):1921-43. PubMed ID: 11708764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Non-motor disorders in patients with muscular dystonia].
    Salouchina NI; Nodel MR; Tolmacheva VA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(9):98-105. PubMed ID: 30335080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pain Relief in Cervical Dystonia with Botulinum Toxin Treatment.
    Camargo CH; Cattai L; Teive HA
    Toxins (Basel); 2015 Jun; 7(6):2321-35. PubMed ID: 26110508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.